Status:

COMPLETED

Remote Monitoring of Interstitial Lung Disease

Lead Sponsor:

patientMpower Ltd.

Collaborating Sponsors:

Quiddity Health Ltd.

Innovate UK

Conditions:

Interstitial Lung Disease

Eligibility:

All Genders

18+ years

Brief Summary

As in-clinic pulmonary function testing is greatly restricted due to Coronavirus Disease 2019 (COVID19), alternative approaches to monitoring patients with long-term respiratory conditions need to be ...

Eligibility Criteria

Inclusion

  • diagnosis of interstitial lung disease
  • Forced Vital Capacity ≥50% predicted (at most recent in-clinic spirometry test)
  • owns a smartphone or tablet device
  • has a mobile telephone number, email address and access to internet at home
  • willing to allow home monitoring of their health including spirometry and pulse oximetry data
  • understands how to use mobile technology (e.g. has downloaded and used other "apps" on their mobile device; uses email)
  • demonstrates willingness to measure spirometry and pulse oximetry daily for the duration of the study
  • fluent in English language
  • Written informed consent.

Exclusion

  • serious concomitant conditions which place the patient at high risk of respiratory distress, making them unsuitable to be managed at home
  • confusion which would limit the patient's understanding of the project or the measurement procedures
  • current or recent (within last 6 weeks before baseline) participation in another clinical research project.

Key Trial Info

Start Date :

August 3 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 7 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04850521

Start Date

August 3 2021

End Date

July 7 2022

Last Update

July 12 2022

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Hampshire Hospitals NHS Foundation Trust

Basingstoke, United Kingdom

2

Imperial College NHS Healthcare Trust

London, United Kingdom

3

Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom

4

Lancashire Teaching Hospitals NHS Foundation Trust

Preston, United Kingdom

Remote Monitoring of Interstitial Lung Disease | DecenTrialz